Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318549 · ClinicalTrials.gov registry record · NA
BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT03318549: Completed NA study, sponsored by University of Miami.
NCT03318549 is a NA study that has completed, run by University of Miami. The registered enrollment target is 115 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03318549, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The purpose of this research study is to better understand the impact of visual impairment caused by different eye diseases on the ability to perform daily activities and compare it to that in patients without eye diseases.
Primary Outcome
The study team will evaluate visual impairment through a composite score of visual functioning test, ranging from 0 to 100, with lower scores indicating worse visual impairment.
Interventions
- DIAGNOSTIC_TEST Visual Performance tests
- DEVICE Brain-computer interface
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2018-10-29 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
What the finished NCT03318549 record still lists
NCT03318549 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Visual Performance tests is the first listed.
NCT03318549 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03318549 about?
NCT03318549 is a clinical study titled "BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases". The purpose of this research study is to better understand the impact of visual impairment caused by different eye diseases on the ability to perform daily activities and compare it to that in patients without eye diseases.
What is the current status of trial NCT03318549?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2018-10-29. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT03318549?
The interventions under investigation include: Visual Performance tests (DIAGNOSTIC_TEST), Brain-computer interface (DEVICE).
Who is sponsoring clinical trial NCT03318549?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03318549's enrollment target sits among peer trials
115 810th of 2000 higher than 1,190 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI